Sanofi is a leading global healthcare company whose mission is to support people with health challenges and satisfy their needs. Sanofi is represented in more than 100 countries all over the world with over 110,000 employees. Sanofi has been present in Russia since 1970 being one of the leaders of Russian pharmaceutical market. A broad diversified portfolio of medical products allows supporting health and well-being of Russian people by protecting them from vaccine preventable diseases and managing serious illnesses in such therapeutic areas as diabetes, cardiovascular diseases, immunology, rare diseases and multiple sclerosis.
Since 2010, Sanofi manufactures the most innovative insulins at the very own site “Sanofi-Aventis Vostok” located in Orel region in line with GMP standards. Since 2012, “Sanofi-Aventis Vostok” also manufactures drugs for oncology therapy.
Being a trusted healthcare partner of Russian government, Sanofi collaborates with medical and patient societies to conduct national epidemiologic studies, to support various social projects dedicated to disease awareness and making sure patients live a better healthier life. A long-term program “Pulse of Health” supports patients receiving cardio-vascular therapy with Sanofi products and helps them purchase prescribed by their doctors product with a discount.
In partnership with the Nanolek company Sanofi has localized manufacturing of pentavalent pediatric vaccine for the National Immunization Calendar. Since 2017, there were over 5 M vaccine doses manufactured on the industrial complex of Nanolek which means that over 1.5M Russian children have received protection from 5 vaccine preventable diseases in the framework of National Immunization Calendar. In November 2019 Sanofi and Nanolek announced the new development phase of their long-term partnership: start of conjugated meningococcal combo vaccine manufacturing.